BrainCheck
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 1.5m | 2.9m | 3.3m | 3.4m | 7.6m | 8.1m |
% growth | - | 93 % | 14 % | 3 % | 124 % | 7 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | $745k | Debt | |
$3.0m | Seed | ||
$1.5m | Seed | ||
* | $1.5m | Debt | |
$8.0m | Series A | ||
$10.0m | Series B | ||
* | $1.5m | Grant | |
* | $15.0m | Late VC | |
Total Funding | $39.0m |
Recent News about BrainCheck
EditBrainCheck is a healthcare technology company specializing in neurocognitive assessments and cognitive care management. The company serves healthcare providers, including physicians and clinics, as well as individual patients who wish to monitor their brain health. Operating in the cognitive health market, BrainCheck offers a robust platform that delivers quick, accurate assessments of brain performance, typically in about 10 minutes. These assessments can be conducted either in-office or remotely, making it convenient for telehealth services. The business model is primarily subscription-based, with healthcare providers and individuals paying for access to the platform and its features. BrainCheck generates revenue through these subscriptions and by offering additional services such as detailed cognitive reports and telehealth integration. The platform is backed by 20 years of research from Baylor College of Medicine and utilizes a normative database validated across various age groups. The company also supports reimbursement through CPT codes like CPT 96138 and CPT 96132, making it financially viable for healthcare providers to integrate BrainCheck into their practice.
Keywords: neurocognitive assessments, cognitive care, telehealth, brain health, remote testing, healthcare technology, subscription model, Baylor College of Medicine, CPT codes, cognitive impairment.